Tyrosine kinase -linked receptors part 1 Cytokine- chemokine signaling
description
Transcript of Tyrosine kinase -linked receptors part 1 Cytokine- chemokine signaling
Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat the University of Pécs and at the University of DebrecenIdentification number: TÁMOP-4.1.2-08/1/A-2009-0011
TYROSINE KINASE-LINKED RECEPTORS PART 1CYTOKINE-CHEMOKINE SIGNALING
Tímea Berki and Ferenc BoldizsárSignal transduction
Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat the University of Pécs and at the University of DebrecenIdentification number: TÁMOP-4.1.2-08/1/A-2009-0011
TÁMOP-4.1.2-08/1/A-2009-0011
Cytokine groupsStructural:1 4 a-helix bundle family• IL-2 subfamily• IFN subfamily• IL-10 subfamily2 IL-1 family3 IL-17 family
Functional: 1 Haematopoietic (EPO,
TPO, G-CSF, GM-CSF, SCF etc.)
2 Lymphocyte differentiation/activationTh1: IL-2, TNF, IFNgTh2: IL-4, IL-5, Il-13; IL-17, IL-23
3 Inflammatory (IL-1, IL-6, TNFa)
TÁMOP-4.1.2-08/1/A-2009-0011
Cytokine receptors
Interferon-a, -β, and -g receptor, IL-10 receptor
Tumor necrosis factor (TNF) receptors I and II, CD40, Fas (Apo1, CD95), CD30, CD27, nerve growth factor receptor
CCR1-10, CXCR1-5, XCR1, CX3CR1
Receptor for IL-2, IL-4, IL-7, IL-9 and IL-15 share a common chain CD132 or gc (common gamma chain). Il-2 receptor also has a third chain, a high affinity subunit IL-2Ra (CD25)
Receptors for erythropoietin, growth hormone, and IL-13
Receptor for IL-3, IL-5, and GM-CSF share a common chain,CD131 or βc (common beta chain)
Class I cytokine receptor (hematopoietin receptor
family)
Class II cytokine receptor
TNF-receptor family
Chemokine-receptor family
a β
TÁMOP-4.1.2-08/1/A-2009-0011
Characteristics of multichain cytokine receptors
gp130
LIF/OSM
IL-6
gp130
IL-11
gp130
CNTF
CNTFR
gp130
GM-CSFRa
GM-CSF
β
IL-3R
IL-3
β
IL-5R
IL-5
β
IL-2Ra
IL-2Rβ
IL-2
g
IL-2Rβ
IL-15Ra
IL-15
g
IL-7R
IL-7
g
IL-9R
IL-9
g
IL-4R
IL-4
g
GM-CSF receptor subfamily(common β subunit)
Il-6 receptor subfamily(common gp130 subunit)
Il-2 receptor subfamily(common g subunit)
TÁMOP-4.1.2-08/1/A-2009-0011
Overview of cytokine signallingCytokine receptors
consist of at least two chains, the
cytoplasmatic domains of which bind Janus
kinases (JAKs)
JAKJAK
Transcription factors (STATs) bind to the
phosphorylated receptors, and are in
turn phosphorylated by the activated JAKs
Phosphorylated STATs form dimers that
translocate into the nucleus to initiate new
gene transcription
JAKJAKPP
P P
JAKJAKPP
JAKJAK
Cytokine binding dimerizes the receptor, bringing together the
cytoplasmic JAKs, which activate each other and
phosphorylate the receptor
JAKJAKPP
PP
PP
P
P
P
P
STAT STAT
TÁMOP-4.1.2-08/1/A-2009-0011
The structure of JAK and STAT proteins
FERM yKI KI"SH2"JH7 JH6 JH5 JH4 JH3 JH2 JH1
0 200 400 600 800 1000 1200
NH2 Coiled coil DBD Lk SH2 TADYP
0 200 400 600 800
JAK structure
STAT structure
TÁMOP-4.1.2-08/1/A-2009-0011
JAK I
FERM yKI KI"SH2"JH7 JH6 JH5 JH4 JH3 JH2 JH1
0 200 400 600 800 1000 1200
KinasePseudokinaseFERM domain: band 4.1, ezrin, radixin
and moesin
JH= Janus homology domain
Proline rich membrane proximal part of
Cytokine Receptors
JAK1JAK2JAK3Tyk2
Y1038/Y1039Y1007/Y1008Y980/Y981Y1054/Y1055
Activation Y residues:
TÁMOP-4.1.2-08/1/A-2009-0011
JAK II
JAK 1 IFN-I/II, IL-2,-4,-6,-10JAK2 IFN-II, IL-3,-5, GM-CSFJAK3 IL-2g,-4,-7,-9,-15,-21TYK2 IFN-I, IL-6,-10,-12,-23
TÁMOP-4.1.2-08/1/A-2009-0011
STAT I
NH2 Coiled coil DBD Lk SH2 TADYP
0 200 400 600 800
DNA-bindingTranscriptional
activationLinker
Receptor recruitmentand dimerizationBinding of
regulatorsDimerizationDNA-binding
Nuclear transport
TÁMOP-4.1.2-08/1/A-2009-0011
Human STATs
Name Chr (Hu) MW (kDa) Function Upstream
STAT1 2q32.2 91 IFN-g/IL-12 axis (Th1 diff.)Y701 EGFR, FGFR3/4, JAK1/2, Lck, KIT, TYK2
STAT2 12q13.3 113 Y690 JAK1S727 PKCd, CamKIIg, Ribosomal protein S6 kinase alpha 5
STAT3 17q21.31 Th17
Y705 FGFR3/4, Hck, JAK1/2, cSrc, EphA3S727 ERK1/2, PKCd, MAPK8, Ribosomal protein S6 kinase alpha 5
STAT42q32.2-q32.3
Th1 S721 MAPK14, MAP2K6
STAT5A 17q11.2 Y694 JAK2, Btk
STAT5B 17q11.2Y679 cSrcY699, 725, 740, 743 EGFR
STAT6 12q13 IL-4 (Th2 diff.) JAK1/2/3
TÁMOP-4.1.2-08/1/A-2009-0011
STAT II
STAT1 IFN-I/II Inflammation
STAT2 IFN-I
STAT3 IL-6 and IL-10 families, IL-21, IL-27
STAT4 IL-12,-23 Th1, Th17
STAT5A and B IL-3,-5, GM-CSF
STAT6 IL-4,-13 Th2, allergy
TÁMOP-4.1.2-08/1/A-2009-0011
Regulation of JAK/STAT signaling• Phosphatases
SHP-1/2, CD45 – JAKSHP-2, PTP1B, TC-PTP, PTP-BL – STAT
• Nuclear export/importNES (nuclear export sequence)NLS (nuclear localization sequence)
• SOCS (suppressors of cytokine signaling) eg. PIAS (Protein Inhibitor of Activated STATs)
• Ser-phosphorylation, acetylation, o-glycosylation of TAD
TÁMOP-4.1.2-08/1/A-2009-0011
JAK inhibitors
Treatment:• Polycythemia vera, thrombocytemia, • Myeloid metaplasia, myelofibrosis• Psoriasis• RAExamples:• Lestaurtinib• Tofacitinib• Ruxolitinib
TÁMOP-4.1.2-08/1/A-2009-0011
Chemokines• 90-130 aa. polypeptidesFunctions:• Chemotaxis for different leukocytes:
– Regulation of normal leukocyte traffic– Recruitment of cells to inflammatory sites
• Enhancement of cell adhesion• Activation of effector leukocytes• Development of the inflammatory reaction• Development of normal lymphoid tissues
TÁMOP-4.1.2-08/1/A-2009-0011Chemokine signal through receptors coupled with G-proteins
Chemokine receptor Ca2+ channels
G protein
cAMP
Adenylylcyclase
Adhesion
Chemotaxis
?
Differentiation, proliferation
Ras
?
Actin polymerization
PLCβ2
DAG IP3
Ca2+PKC
Cytoskeletal rearrangment
?
GDP
gβa
GTP
a gβ
TÁMOP-4.1.2-08/1/A-2009-0011
Chemokine signaling pathways
Chemokinereceptor
Ca2+ channel
Gene expression and apoptosis
Chemokines
Ca2+
Ca2+
RAS
DAG
JNKp38Ras
pathway
gβ
GRB2
NF-B c-Jun
c-Fos
STAT5
PKC Ca2+
PYK2
Crk
CAS
GTP
a
Elk-1
MAPKpathway
PTK
Cell activation
PLA2
Rhopathway
Rho
SRF
InternalizationDegradation
Recycling
GRK
β-Arrestin
PLCβ
PKCβ
PLCg
PI3K
Akt/PKBpathway
Akt/PKB
PDK
NF-BElk-1 Elk-1
Plasma membrane
Cytoplasm
Nucleus
PIP2
IP3
GDP
gβaJAK2